• Thumbnail for SARS-CoV-2 Alpha variant
    The Alpha variant (B.1.1.7) was a SARS-CoV-2 variant of concern. It was estimated to be 40–80% more transmissible than the wild-type SARS-CoV-2 (with most...
    219 KB (18,220 words) - 23:46, 31 March 2024
  • Thumbnail for SARS-CoV-2 Omicron variant
    Omicron variant Variants of SARS-CoV-2 Other variants of either interest or concern: Alpha, Beta, Gamma, Delta, Epsilon, Zeta, Eta, Theta, Iota, Kappa, Lambda...
    223 KB (24,632 words) - 14:28, 12 July 2024
  • Thumbnail for SARS-CoV-2 Beta variant
    The Beta variant, (B.1.351), was a variant of SARS-CoV-2, the virus that causes COVID-19. One of several SARS-CoV-2 variants initially believed to be...
    72 KB (6,070 words) - 08:16, 5 June 2024
  • Thumbnail for SARS-CoV-2
    30, 2020, to May 5, 2023. SARSCoV2 is a positive-sense single-stranded RNA virus that is contagious in humans. SARSCoV2 is a strain of the species...
    122 KB (12,466 words) - 03:45, 13 July 2024
  • Thumbnail for COVID-19 pandemic
    pandemic), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), began with an outbreak of COVID-19 in Wuhan, China, in December 2019...
    368 KB (32,620 words) - 02:42, 30 July 2024
  • Thumbnail for Origin of SARS-CoV-2
    to the SARS-CoV-1 and MERS-CoV outbreaks, and consistent with other pandemics in human history. Available evidence suggests that the SARS-CoV-2 virus was...
    116 KB (13,429 words) - 10:53, 13 July 2024
  • Thumbnail for COVID-19
    COVID-19 (redirect from COV-19)
    the coronavirus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019. Most scientists believe the SARS-CoV-2 virus entered...
    289 KB (33,267 words) - 07:41, 30 July 2024
  • acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19). Prior to...
    199 KB (22,720 words) - 00:31, 31 July 2024
  • Thumbnail for Zoonotic origins of COVID-19
    has an expanded host range compared to SARS-CoV-1 and MERS-CoV. SARS-CoV-2 (along with SARS-CoV-1 and MERS-CoV) are generalist viruses, not specifically...
    43 KB (5,157 words) - 06:29, 30 June 2024
  • Thumbnail for Cluster 5
    Serum Institut for a virus variant described by the institute in autumn 2020, in connection with investigations of SARS-CoV-2 infection among mink and humans...
    33 KB (3,495 words) - 08:12, 24 July 2024
  • Thumbnail for COVID-19 testing
    COVID-19 testing (category CS1 foreign language sources (ISO 639-2))
    involves analyzing samples to assess the current or past presence of SARS-CoV-2, the virus that cases COVID-19 and is responsible for the COVID-19 pandemic...
    181 KB (21,044 words) - 08:55, 1 July 2024
  • Thumbnail for Face masks during the COVID-19 pandemic
    as public and personal health control measures against the spread of SARS-CoV-2, the virus that causes COVID-19. In community and healthcare settings...
    225 KB (23,850 words) - 06:31, 24 July 2024
  • Thumbnail for Oxford–AstraZeneca COVID-19 vaccine
    June 2021. Retrieved 29 June 2021 – via Knowledge Hub. SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 17...
    214 KB (17,120 words) - 01:50, 16 July 2024
  • Thumbnail for Timeline of the COVID-19 pandemic in January 2020
    This article documents the chronology and epidemiology of SARS-CoV-2 in January 2020, the virus which causes the coronavirus disease 2019 (COVID-19) and...
    193 KB (17,514 words) - 01:04, 29 March 2024
  • Thumbnail for COVID-19 vaccine misinformation and hesitancy
    (2021). "Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination...
    132 KB (12,893 words) - 23:23, 31 July 2024
  • Thumbnail for Timeline of the COVID-19 pandemic in March 2020
    Timeline of the COVID-19 pandemic in March 2020 (category CS1 foreign language sources (ISO 639-2))
    This article documents the chronology and epidemiology of SARS-CoV-2 in March 2020, the virus which causes the coronavirus disease 2019 (COVID-19) and...
    110 KB (6,824 words) - 19:17, 21 June 2024
  • Thumbnail for COVID-19 vaccine clinical research
    Staropoli I, Guivel-Benhassine F, Rajah MM, et al. (August 2021). "Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization". Nature. 596...
    95 KB (18,965 words) - 15:46, 23 June 2024
  • Thumbnail for COVID-19 drug repurposing research
    and the general replication kinetics and the biology of the MERS, SARS and [SARS-CoV-2] viruses are very similar, so testing drugs which target relatively...
    128 KB (14,900 words) - 01:44, 16 July 2024
  • Thumbnail for COVID-19 vaccination in Switzerland
    immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response...
    13 KB (1,068 words) - 20:37, 16 May 2024
  • Thumbnail for COVID-19 drug development
    2, known as SARS-CoV-2. It was developed by GlaxoSmithKline and Vir Biotechnology, Inc. Sotrovimab is designed to attach to the spike protein of SARS-CoV-2...
    90 KB (13,103 words) - 04:28, 26 July 2024
  • Thumbnail for Public health mitigation of COVID-19
    endemic existence of SARS-CoV-2 is likely to be long and erratic, rather than a short and distinct switch, and that endemic SARS-CoV-2 is by far not a synonym...
    46 KB (4,852 words) - 05:03, 26 July 2024
  • Thumbnail for Buprenorphine
    Buprenorphine (category Kappa-opioid receptor antagonists)
    PMID 19077058. Grinnell S et al. (2014): Buprenorphine analgesia requires exon 11-associated mu opioid receptor splice variants. The FASEB Journal Colasanti...
    80 KB (7,311 words) - 17:06, 31 May 2024
  • Thumbnail for Sinopharm CNBG COVID-19 vaccine
    based on the original, and the Beta (K417N/E484K/N501Y) and Kappa (L452R/E484K) variants. "Emergency use of Sinopharm's new CNBG protein vaccine approved...
    4 KB (211 words) - 12:17, 24 January 2024
  • Thumbnail for COVID-19 pandemic in Europe
    COVID-19 pandemic in Europe (category CS1 Estonian-language sources (et))
    Retrieved 11 January 2021. "New COVID-19 Variant in the UK". gov.uk/government/collections/new-sars-cov-2-variant. Retrieved 11 January 2021. "Approval by...
    203 KB (22,836 words) - 03:17, 23 July 2024
  • Thumbnail for COVID-19 pandemic in Oceania
    as confirmed cases, but this is not necessarily indicative of active SARS-CoV-2 infection due to most COVID-19 tests analysing past presence of the virus...
    97 KB (8,652 words) - 02:10, 15 June 2024
  • Thumbnail for COVID-19 pandemic in South America
    (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of 3 August 2024, a total of 10,113,624 people were confirmed to...
    22 KB (5,762 words) - 02:10, 15 June 2024
  • Thumbnail for COVID-19 pandemic on naval ships
    militaries may have policies in place that prevent or restrict reporting of SARS-CoV-2 infections and COVID-19 deaths, so although the cases listed below may...
    93 KB (6,933 words) - 06:54, 8 July 2024
  • Thumbnail for COVID-19 lockdowns
    targeted lockdowns. The emergence of the highly transmissible SARS-CoV-2 Delta variant in 2021 has led some commentators to suggest that although lockdowns...
    73 KB (15,197 words) - 21:56, 3 August 2024
  • Thumbnail for COVID-19 lockdowns by country
    the third wave of the COVID-19 pandemic in the province caused by SARS-CoV-2 variants, the government of Ontario once again announced a four-week provincewide...
    171 KB (20,297 words) - 13:35, 12 May 2024
  • Thumbnail for Addiction
    factor delta FosB is increased in the NAc, PFC, dorsal striatum, and VTA following repeated sexual behavior (Wallace et al., 2008; Pitchers et al., 2010b)...
    266 KB (31,201 words) - 17:38, 31 July 2024